{"disease":{"id":"hematopoietic-cell-transplant","name":"hematopoietic cell transplant"},"drugs":{"marketed":[{"drug_id":"narsoplimab","indication_name":"hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Yartemlea","generic_name":"NARSOPLIMAB","company_name":"Omeros Corp","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":40,"revenue":null,"mechanism":"Narsoplimab works by targeting and modulating the immune system to prevent damage to blood vessels."},{"drug_id":"busilvex","indication_name":"Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Busilvex","company_name":"medac GmbH","drug_phase":"phase_2","molecular_target":"Matrix metalloproteinase-9","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"mycophenolate-mofetil","indication_name":"The suppression of graft-versus-host disease in hematopoietic stem cell transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cellcept","generic_name":"MYCOPHENOLATE MOFETIL","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Inosine-5'-monophosphate dehydrogenase 2","drug_class":"Antimetabolite Immunosuppressant","quality_score":10,"revenue":null,"mechanism":"Cellcept works by inhibiting the enzyme inosine-5'-monophosphate dehydrogenase 2, which is necessary for the production of guanosine nucleotides."},{"drug_id":"busulfan","indication_name":"Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Busulfex","generic_name":"busulfan","company_name":"Waylis","drug_phase":"marketed","molecular_target":"Matrix metalloproteinase-9","drug_class":"Alkylating Drug [EPC]","quality_score":10,"revenue":null,"mechanism":"Busulfex works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death."},{"drug_id":"busulfex","indication_name":"Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"busulfex","company_name":"Dana-Farber Cancer Institute","drug_phase":"marketed","molecular_target":"Matrix metalloproteinase-9","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"busulphan","indication_name":"Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Busulphan","company_name":"University of Birmingham","drug_phase":"discontinued","molecular_target":"Matrix metalloproteinase-9","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07349498","title":"Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT00736749","title":"Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT06708130","title":"Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT03000244","title":"Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07205523","title":"High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Yigeng Cao,MD,PhD","has_results":false},{"nct_id":"NCT03357172","title":"Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT00674882","title":"Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant","phase":"","overall_status":"COMPLETED","enrollment_count":637,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT07463651","title":"MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":594,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT01877655","title":"A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":514,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":true},{"nct_id":"NCT07028112","title":"Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04786002","title":"Target Busulfan Exposure in Children With HSCT in China","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT05090345","title":"A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT05722210","title":"Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT04788420","title":"Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML","phase":"","overall_status":"COMPLETED","enrollment_count":456,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06673459","title":"BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":430,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT07442513","title":"Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":404,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT06328127","title":"Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04690933","title":"AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"University Hospital, Limoges","has_results":false},{"nct_id":"NCT07157670","title":"Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04674345","title":"Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":346,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06705062","title":"Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":316,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT05290545","title":"Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT07490392","title":"Growth and Endocrinological Outcomes in Patients Who Underwent or Did Not Undergo Haematopoietic Stem Cell Transplantation in Prepubertal Age","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT07210242","title":"HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Ting YANG","has_results":false},{"nct_id":"NCT05355675","title":"The Association of Microbiota Composition With cGVHD After Allo-HSCT","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT07286461","title":"VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":290,"lead_sponsor_name":"University of Rome Tor Vergata","has_results":false},{"nct_id":"NCT06198517","title":"Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT","phase":"NA","overall_status":"RECRUITING","enrollment_count":266,"lead_sponsor_name":"Yi Zhang","has_results":false},{"nct_id":"NCT04203108","title":"ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":266,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT05436418","title":"The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03689465","title":"PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":260,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03733340","title":"Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04713956","title":"G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":242,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03803696","title":"Multimodal Sexual Dysfunction Intervention In HCT","phase":"NA","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT06916195","title":"Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":230,"lead_sponsor_name":"MSD Italia S.r.l.","has_results":false},{"nct_id":"NCT04942886","title":"Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":226,"lead_sponsor_name":"Seoul St. Mary's Hospital","has_results":false},{"nct_id":"NCT07362810","title":"G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":224,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05605574","title":"Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant","phase":"NA","overall_status":"RECRUITING","enrollment_count":222,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05151406","title":"Myths and Misconceptions About HSCT in a Limited Resource Region","phase":"NA","overall_status":"COMPLETED","enrollment_count":218,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07425782","title":"Venetoclax Combined With Azacitidine for Consolidation Therapy in AML","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":216,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT03727113","title":"Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors","phase":"","overall_status":"COMPLETED","enrollment_count":211,"lead_sponsor_name":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","has_results":false},{"nct_id":"NCT05166967","title":"Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":204,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT03654599","title":"Effects of Digital Stories Intervention on Psychosocial Well-being","phase":"NA","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Arizona State University","has_results":true},{"nct_id":"NCT02474290","title":"Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT02744742","title":"G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04146870","title":"Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT07101588","title":"Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT04580576","title":"Gender Differences in Pediatric Hematopoietic Stem Cell Transplantation (HSCT)","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"IRCCS Burlo Garofolo","has_results":false},{"nct_id":"NCT05663502","title":"Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":false},{"nct_id":"NCT05789615","title":"Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT05667428","title":"A Multicenter Open-label Clinical Study on the Prevention of Premature Ovarian Failure After HSCT","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}